US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% SKHY $195.02 ▲+0.00% SNDK $1,704.16 ▲+0.00% TSLA $378.73 ▲+0.00% SDEV $3.94 ▲+0.00% INTC $116.19 ▲+0.00%
FinancialContent

Articles published by AnaCardio

News headline image
AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readiness
From AnaCardio
Via GlobeNewswire
News headline image
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
From AnaCardio
Via GlobeNewswire